Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OMT vs Ibuprofen for Acute Low Back Pain in ED
NCT04129437Phase 4Unknown
- Sponsor
- Einstein Healthcare Network
- Start
- Feb 2020
- Primary completion
- Jan 2023
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial (3 arms), sponsored by Einstein Healthcare Network. Primary endpoint: Pain score (VAS) at 45 minutes. Status: unknown.
Beyond the preview
Go deeper on NCT04129437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04129437.